멥스젠
Seoul, KR · 4 known investors
Find your way into 멥스젠
MEPSGEN develops microphysiological systems (MPS) and organ-on-chip technologies for drug development and testing, serving pharmaceutical companies and contract research organizations. The company manufactures nanoparticles and microspheres, produces automated robotic systems for MPS modeling, and develops nanomedicines for diseases including glioblastoma and Alzheimer's disease.
Investors · 4
Frequently asked questions
- What does 멥스젠 do?
- MEPSGEN develops microphysiological systems (MPS) and organ-on-chip technologies for drug development and testing, serving pharmaceutical companies and contract research organizations. The company manufactures nanoparticles and microspheres, produces automated robotic systems for MPS modeling, and develops nanomedicines for diseases including glioblastoma and Alzheimer's disease.
- Who are 멥스젠's investors?
- 멥스젠's investors include Kolon Investment, Inc., Korea Investment Partners, SBI Investment Korea Co. Ltd., Solidus Investment.
- Where is 멥스젠 headquartered?
- 멥스젠 is headquartered in Seoul, KR.